Guy Macdonald

CIK 1296998 · President and Chief Executive · last filed 2025-06-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$329.9K

Companies

3

Total Filings

65

Lifetime Open-Market Net

-$7.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCYX Director 78,000 $4.23 $329.9K $145.6K 33 2025-06-30
TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted President and Chief Executive 0 -$7.82M 30 2020-07-29
IDENIX PHARMACEUTICALS INC (IDIX) Delisted Executive VP, Operations $0 2 2007-06-04

Recent Filings · Page 3 of 7

65 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-01-04 SCYX Grant (A) $0 EDGAR
2017-10-04 SCYX Grant (A) $0 EDGAR
2017-07-05 SCYX Grant (A) $0 EDGAR
2017-04-04 SCYX Grant (A) $0 EDGAR
2017-02-13 TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted Exer (M) +30,378 $88.1K EDGAR
2017-02-01 TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted Grant (A) +3,204 $0 EDGAR
2017-01-05 SCYX Grant (A) $0 EDGAR
2017-01-05 SCYX Grant (A) $0 EDGAR
2016-10-04 SCYX Grant (A) $0 EDGAR
2016-07-11 SCYX Grant (A) $0 EDGAR
Showing 2130 of 65
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.